C07D 333/72
Benzo[c]thiophenes
Official title: Benzo[c]thiophenes; Hydrogenated benzo[c]thiophenes
C07D333/72 (Benzo[c]thiophenes) appears on 115 US grants and 119 published applications in this corpus.
Search patents in C07D- Granted patents
- 115
- Published applications
- 119
- Assignees
- 93
- Inventors
- 433
- Latest grant
- 5 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 6 | 0 |
| 1977 | 2 | 0 |
| 1978 | 0 | 0 |
| 1979 | 2 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 5 | 0 |
| 1993 | 5 | 0 |
| 1994 | 4 | 0 |
| 1995 | 0 | 0 |
| 1996 | 2 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 2 | 0 |
| 2001 | 3 | 1 |
| 2002 | 5 | 3 |
| 2003 | 2 | 4 |
| 2004 | 2 | 5 |
| 2005 | 2 | 0 |
| 2006 | 0 | 7 |
| 2007 | 1 | 4 |
| 2008 | 4 | 15 |
| 2009 | 3 | 6 |
| 2010 | 4 | 8 |
| 2011 | 6 | 6 |
| 2012 | 4 | 2 |
| 2013 | 5 | 4 |
| 2014 | 6 | 3 |
| 2015 | 5 | 5 |
| 2016 | 3 | 7 |
| 2017 | 2 | 4 |
| 2018 | 3 | 4 |
| 2019 | 5 | 6 |
| 2020 | 3 | 3 |
| 2021 | 3 | 4 |
| 2022 | 2 | 3 |
| 2023 | 3 | 4 |
| 2024 | 2 | 6 |
| 2025 | 1 | 3 |
| 2026 | 1 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Crystal form of thiophene derivative and preparation method therefor5 May 2026US 12,617,766 B2Tonghua Dongbao Pharmaceutical Co., Ltd.
- Benzothiophene derivative regulator, preparation method therefor and use thereof4 Nov 2025US 12,459,931 B2Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
- Compositions and methods for the treatment of cancer24 Sep 2024US 12,098,117 B2Duke University
- Arylamide derivative having antitumor activity23 Apr 2024US 11,964,950 B2Chugai Seiyaku Kabushiki Kaisha
- Condensed cyclic compound and organic light-emitting device including the same4 Jul 2023US 11,691,957 B2Samsung Electronics Co., Ltd.
- Thienyl compounds for the treatment of a central nervous system disease or disorder17 Sep 2026US 2026/0274814 A1
- Pi3k-alpha inhibitors and methods of use thereof5 Feb 2026US 2026/0035335 A1Relay Therapeutics, Inc.
- Pi3k-alpha inhibitors and methods of use thereof9 Oct 2025US 2025/0313524 A1Relay Therapeutics, Inc.
- Heterocyclic glp-1 agonists12 Jun 2025US 2025/0188103 A1Gasherbrum Bio, Inc.
- Sortilin inhibitors2 Jan 2025US 2025/0002460 A1Sortina Pharma AB
Most cited
By later US patents
- Npyy5 antagonists74US 6,699,891 B1Shionogi & Co., Ltd. · 2004
- Derivatization of non-natural amino acids and polypeptides61US 7,385,028 B2Ambrx, Inc. · 2008
- Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides60US 7,332,571 B2Ambrx, Inc. · 2008
- Photoelectric conversion device, photoelectric conversion device material, photosensor and imaging device52US 8,525,577 B2FUJIFILM Corporation · 2013
- Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides39US 7,696,312 B2Ambrx, Inc. · 2010